Lupin Limited (LUPIN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lupin Limited (LUPIN) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs29.03 Billion ≈ $313.93 Million USD) by net assets (Rs197.28 Billion ≈ $2.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Lupin Limited market cap and net worth for the company's overall valuation and market capitalisation.
Lupin Limited - Cash Flow Conversion Efficiency Trend (2004–2026)
This chart illustrates how Lupin Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lupin Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lupin Limited ranked by their cash flow conversion efficiency. Explore Lupin Limited earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BALOISE HLDG AG ADR/1/10
F:BLO
|
N/A |
|
Eurofins Scientific SE
PA:ERF
|
0.220x |
|
The AES Corporation
NYSE:AES
|
0.128x |
|
SK TELECOM CO.LTD.ADR 5/9
F:KMBA
|
0.085x |
|
Camden Property Trust
NYSE:CPT
|
0.036x |
|
China Pacific Insurance (Group) Co. Ltd
F:75C
|
0.102x |
|
Mankind Pharma Ltd
NSE:MANKIND
|
0.099x |
|
Shenzhen Megmeet Electrical Co Ltd
SHE:002851
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Lupin Limited (2004–2026)
The table below shows the annual cash flow conversion efficiency of Lupin Limited from 2004 to 2026. View LUPIN stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs225.13 Billion ≈ $2.43 Billion |
Rs71.90 Billion ≈ $777.56 Million |
0.319x | +84.11% |
| 2025-03-31 | Rs172.94 Billion ≈ $1.87 Billion |
Rs30.00 Billion ≈ $324.43 Million |
0.173x | -31.66% |
| 2024-03-31 | Rs143.73 Billion ≈ $1.55 Billion |
Rs36.48 Billion ≈ $394.56 Million |
0.254x | +67.83% |
| 2023-03-31 | Rs125.43 Billion ≈ $1.36 Billion |
Rs18.97 Billion ≈ $205.15 Million |
0.151x | +403.24% |
| 2022-03-31 | Rs122.22 Billion ≈ $1.32 Billion |
Rs3.67 Billion ≈ $39.72 Million |
0.030x | -77.14% |
| 2021-03-31 | Rs138.58 Billion ≈ $1.50 Billion |
Rs18.22 Billion ≈ $197.02 Million |
0.131x | +12.60% |
| 2020-03-31 | Rs125.81 Billion ≈ $1.36 Billion |
Rs14.69 Billion ≈ $158.85 Million |
0.117x | -3.37% |
| 2019-03-31 | Rs137.89 Billion ≈ $1.49 Billion |
Rs16.66 Billion ≈ $180.17 Million |
0.121x | -6.05% |
| 2018-03-31 | Rs136.17 Billion ≈ $1.47 Billion |
Rs17.51 Billion ≈ $189.38 Million |
0.129x | -57.69% |
| 2017-03-31 | Rs135.32 Billion ≈ $1.46 Billion |
Rs41.14 Billion ≈ $444.86 Million |
0.304x | +1022.36% |
| 2016-03-31 | Rs111.95 Billion ≈ $1.21 Billion |
Rs-3.69 Billion ≈ $-39.90 Million |
-0.033x | -110.73% |
| 2015-03-31 | Rs88.98 Billion ≈ $962.30 Million |
Rs27.33 Billion ≈ $295.57 Million |
0.307x | +7.27% |
| 2014-03-31 | Rs69.99 Billion ≈ $756.86 Million |
Rs20.04 Billion ≈ $216.72 Million |
0.286x | +20.48% |
| 2013-03-31 | Rs52.64 Billion ≈ $569.24 Million |
Rs12.51 Billion ≈ $135.29 Million |
0.238x | +73.36% |
| 2012-03-31 | Rs40.85 Billion ≈ $441.80 Million |
Rs5.60 Billion ≈ $60.57 Million |
0.137x | -42.67% |
| 2011-03-31 | Rs33.33 Billion ≈ $360.41 Million |
Rs7.97 Billion ≈ $86.18 Million |
0.239x | -8.32% |
| 2010-03-31 | Rs25.93 Billion ≈ $280.46 Million |
Rs6.76 Billion ≈ $73.15 Million |
0.261x | -20.06% |
| 2009-03-31 | Rs14.39 Billion ≈ $155.63 Million |
Rs4.70 Billion ≈ $50.78 Million |
0.326x | +62.70% |
| 2008-03-31 | Rs12.89 Billion ≈ $139.41 Million |
Rs2.59 Billion ≈ $27.96 Million |
0.201x | -1.57% |
| 2007-03-31 | Rs8.73 Billion ≈ $94.45 Million |
Rs1.78 Billion ≈ $19.24 Million |
0.204x | -8.77% |
| 2006-03-31 | Rs5.89 Billion ≈ $63.68 Million |
Rs1.32 Billion ≈ $14.22 Million |
0.223x | +18.37% |
| 2005-03-31 | Rs4.91 Billion ≈ $53.05 Million |
Rs925.60 Million ≈ $10.01 Million |
0.189x | -79.18% |
| 2004-03-31 | Rs4.32 Billion ≈ $46.67 Million |
Rs3.91 Billion ≈ $42.29 Million |
0.906x | -- |
About Lupin Limited
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic … Read more